If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    -0.50 (-1.85%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.95m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Interim Results

18 Dec 2006 07:01

Merchant Securities PLC18 December 2006 Merchant Securities plc ("the Company") 18th December 2006 INTERIM REPORT TO SHAREHOLDERS Chairman's statement I have pleasure in presenting the interim results for Merchant Securities plc('the Company') for the six months ended 30th September 2006. During thisperiod, the Company was known as Castor Investments plc. On 25th October 2006,the Company changed its name to Merchant Securities plc following itsacquisition of Merchant Securities Holdings Limited ("MSHL") for £8.35 million. The transaction was effected by issuing 16,700,000 new Ordinary Shares of 10peach at a price of 50p per share. On completion of the acquisition, theexisting directors, David Barton and Alan Pereira, resigned, and the followingdirectors were appointed: Anthony Fabrizi (Chief Executive), Patrick Claridge(Executive Director), Steven Whelton (Finance Director), John Green (Chairman)and Charles Price (Non-Executive Director). The Company's original strategy had been to acquire one or more relatedbusinesses in the health care and life sciences sectors, but it could notidentify suitable acquisitions within those sectors. Trading of the Company'sshares on AIM was suspended on 3rd April 2006, and the new shares werere-admitted following the acquisition. The results reported herein relate to the period before the takeover of MSHL anddo not reflect the group's current business activities. The Company suffered atrading loss for the period of £13,000. At 30th September 2006, the Company hada cash balance of £216,000, and an investment of 1.25 million shares in Phynovaplc (a company listed on AIM) carried at cost of £750,000. Subsequent to theend of the period, the Company sold 600,000 of its shares in Phynova plc for£448,500, thus realising a gain on disposal of £88,500. At 30th November 2006,the group had net cash balances of approximately £2.65 million. On 4th December 2006, the Company changed its business address and RegisteredOffice to John Stow House, 18 Bevis Marks, London, EC3A 7BJ. John Green Chairman Enquiries: Merchant Securities plc Anthony Fabrizi (Chief Executive) Tel: 020 7375 9010 Arden Partners plc Paul Davis Tel: 020 7398 1635 Broadgate Roland Cross Tel: 020 7726 6111 About Merchant Securities plc Merchant Securities plc provides a range of financial services to privateclients, institutions and small businesses. The Company's main operatingsubsidiary, Merchant Securities Group Limited, is authorised by the FinancialServices Authority and provides a variety of services, including asset andadvisory management to over 850 high net worth private clients, sales trading toinstitutional investors, and private equity funding and corporate advice tosmall UK companies. MERCHANT SECURITIES PLC Interim unaudited accounts for the six months ended 30th September 2006 PROFIT AND LOSS ACCOUNT Period ended Period ended Period ended 30th September 31st July 31st March 2006 2005 2006 Unaudited Unaudited Audited £000 £000 £000 Turnover - - -Administrative expenses (18 ) (95 ) (72 ) Operating loss (18 ) (95 ) (72 ) Interest receivable and similar income 5 17 46 Loss on ordinary activities before and after taxation (13 ) (78 ) (26 ) LOSS PER ORDINARY SHARE (PENCE) (NOTE 2) Basic (0.05 ) (0.29 ) (0.10 )Diluted (0.05 ) (0.29 ) (0.10 ) All amounts relate to continuing activities. All recognised gains and losses are shown in the Profit and Loss Account. RECONCILIATION OF MOVEMENT IN SHAREHOLDERS FUNDS Loss for the period (13 ) (78 ) (26 )Shares issued - 272 272Share premium - 788 788Other reserves and deficits - - (59 )Opening shareholders' funds 975 - -Closing shareholders' funds 962 982 975 BALANCE SHEET 30th September 31st July 31st March 2006 2005 2006 Unaudited Unaudited Audited £000 £000 £000 Current AssetsDebtors 75 - 4Investments 750 - 750Cash at bank and in hand 216 982 252 1,041 982 1,006Creditors: amounts falling due in less than one year (79 ) - (31 )Net assets 962 982 975 Capital and reservesCalled up share capital 272 272 272Share premium account 704 788 704Share warrant reserve 25 - 25Profit and loss account (39 ) (78 ) (26 )Shareholders' funds 962 982 975 CASH FLOW STATEMENT 30th September 31st July 31st March 2006 2005 2006 Unaudited Unaudited Audited £000 £000 £000 Net cash outflow from operating activities (41 ) (95 ) (44 )Return on investments and servicing offinanceInterest received 5 17 46Financial investmentAcquisition of current asset investment - - (750 )Net cash outflow before financing (36 ) (78 ) (748 ) FinancingIssues of ordinary shares for cash - 1,060 1,060Share issue expenses - - (60 )Net cash inflow from financing - 1,060 1,000 Increase(/decrease) in cash for the period (36 ) 982 252 NOTES Note 1 - Basis of preparation The interim accounts have been prepared in accordance with applicable accountingstandards and under the historic cost convention. The financial information set out in this interim statement, does not constitutestatutory accounts within the meaning of Section 240 of the Companies Act 1985. Note 2 - Loss per share The loss per share is calculated based on: Period ended Period ended Period ended 30th September 31st July 31st March 2006 2005 2006 Unaudited Unaudited Audited Loss for the period (£000) (13 ) (78 ) (26 )Weighted average number of shares in issue 27,200 27,200 25,868(000) Note 3 - Dividend The directors do not recommend the payment of an interim dividend. Note 4 - Interim statement The interim statement is available to the public from the Company's registeredoffice at John Stow House, 18 Bevis Marks, London EC3A 7JB. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Sep 20197:00 amRNS£7.5million syndicated investment into Voxpopme
1st Aug 20197:00 amRNSGrant of Options
29th Jul 20192:24 pmRNSNotification of Major Holdings
26th Jul 20197:00 amRNSPublication of Annual Report
8th Jul 20197:00 amRNSPreliminary Results
5th Jul 201910:00 amRNSChange of Name
2nd Jul 20197:00 amRNSDirectorate Change
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.